
The drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The regulator's subject expert committee (SEC) will examine data submitted by Cadila, reports Sushmi Dey.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2T4Tm17
via
IFTTT
0 comments:
Post a Comment